CYCN stock forecast
Our latest prediction for Cyclerion Therapeutics, Inc.'s stock price was made on the Nov. 8, 2019 when the stock price was at 1.90$.
In the short term (2weeks), CYCN's stock price should outperform the market by 2.62%. During that period the price should oscillate between -11.58% and +46.91%.
In the medium term (3months), CYCN's stock price should outperform the market by 4.62%. During that period the price should oscillate between -25.77% and +115.21%.Get email alerts
Create a solid portfolio with CYCN
About Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -4.67$ per share.
The book value per share is 5.15$
Three months stock forecastNov. 8, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|